Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Small Pharma Inc.
Small Pharma Reports Fiscal Second Quarter 2024 Highlights
October 19, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders
October 12, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
September 26, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Fiscal First Quarter 2024 Highlights
July 27, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces SPL028 R&D Strategy Update
July 05, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Management Team Change
July 05, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights
June 28, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Significant Developments In Intellectual Property Portfolio
May 25, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology
May 03, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026
April 04, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry
March 07, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results
March 07, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028
February 15, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue
February 01, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Fiscal Third Quarter 2023 Highlights
January 25, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder
January 25, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25
January 24, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026
January 09, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property
December 22, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
First Patient Dosed in Small Pharma’s Drug Interaction Study
December 15, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma To Support University College London Research Project on Neuroplasticity
December 14, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium
December 08, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma to Participate in November Investor and Healthcare Conferences
November 11, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028
October 31, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio
October 19, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
October 14, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation
July 26, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Tickers
DMTTF
TSX-V:DMT
Small Pharma Inc.: World’s First Clinical Trial For DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I
February 22, 2022
From
Small Pharma Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.